Home/Filings/4/0000904454-26-000013
4//SEC Filing

Kaye Jack 4

Accession 0000904454-26-000013

CIK 0001590560other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 4:21 PM ET

Size

9.3 KB

Accession

0000904454-26-000013

Insider Transaction Report

Form 4
Period: 2026-01-09
Kaye Jack
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares

    [F1]
    2026-01-09$19.39/sh+6,390$123,90226,829 total
  • Sale

    Ordinary Shares

    [F1][F2]
    2026-01-09$27.28/sh6,390$174,31920,439 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F3]
    2026-01-096,3900 total
    Exercise: $19.39Exp: 2028-01-26Ordinary Shares (6,390 underlying)
Footnotes (3)
  • [F1]The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.19 to $27.39. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The Stock Option vested in full on January 26, 2019.
Signature
/s/ Christian Klemt, Attorney-in-Fact|2026-01-12

Issuer

uniQure N.V.

CIK 0001590560

Entity typeother

Related Parties

1
  • filerCIK 0001376099

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:21 PM ET
Size
9.3 KB